aica ribonucleotide and Hematologic Malignancies

aica ribonucleotide has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bouscary, D; Chapuis, N; Green, AS; Lacombe, C; Mayeux, P; Tamburini, J	1

Reviews

1 review(s) available for aica ribonucleotide and Hematologic Malignancies

Article	Year
LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biology. Cell cycle (Georgetown, Tex.), 2011, Jul-01, Volume: 10, Issue:13 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Hematologic Neoplasms; Humans; Hypoglycemic Agents; Metformin; Neoplasms; Protein Serine-Threonine Kinases; Ribonucleotides; Signal Transduction; TOR Serine-Threonine Kinases	2011

Article

Year

LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biology.

Cell cycle (Georgetown, Tex.), 2011, Jul-01, Volume: 10, Issue:13

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Hematologic Neoplasms; Humans; Hypoglycemic Agents; Metformin; Neoplasms; Protein Serine-Threonine Kinases; Ribonucleotides; Signal Transduction; TOR Serine-Threonine Kinases

2011